Initial investigation into the metabolic effects of intra-articular betamethasone on normal and insulin dysregulated horses.

The research article explores the metabolic impact of intra-articular betamethasone on normal horses and those with insulin regulation issues, uncovering effects such as suppression of ACTH and cortisol, and increased glucose levels in non-insulin dysregulated horses.

Research Objectives and Methodology

• The primary objective of the study was to examine the metabolic effects of intra-articular (IA) corticosteroids, specifically betamethasone, on horses with different types of insulin regulation ─ insulin dysregulated (ID) and non-ID.
• A total of eight geldings were utilized in a cross-over design, where they were injected with either 9mg of betamethasone or saline into the metacarpophalangeal joints.
• Subsequent regular blood samples were taken for different hormonal analysis like adrenocorticotropin releasing hormone (ACTH), cortisol, insulin, and glucose, along with oral sugar tests both before and after the administration of the drug.
• Statistical analysis was performed using a two-way repeated measures analysis of variance, with a significance level set at p < 0.05.

Key Findings

• The results indicated that intra-articular betamethasone causes significant suppression of both ACTH and cortisol in both types of horses (ID and non-ID), lasting for 24-48 hours post-administration.
• In non-insulin dysregulated horses, a significant increase in glucose levels was observed between 8-48 hours post-administration.

Implications and Future Research

• The study provides preliminary insights into the metabolic changes caused by intra-articular corticosteroids in horses. Understanding these changes can influence the therapeutic use of such drugs, with attention to potential side effects on blood glucose and hormone levels.
• One limitation of the study is the underpowered analysis of insulin, primarily due to the small sample size used.
• The authors suggest that future studies should consider larger representative samples of both ID and non-ID horses to better elucidate these effects and facilitate a more robust analysis of insulin concentrations.